Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:26 AM
Ignite Modification Date:
2025-12-25 @ 3:26 AM
NCT ID:
NCT01795105
Eligibility Criteria:
Inclusion Criteria:
* Pediatric patients 6 to 18 years of age with Tourette's Disorder
* Patients who are prescribed Abilify® treatment as per investigator's medical judgment.
* Patients who gave written authorization to use their personal and health data
* Patients starting Abilify® treatment after agreement is in place
Exclusion Criteria:
* Patients with known hypersensitivity to Aripiprazole or any excipients of Abilify®
* Patients who have been treated with Abilify®
* Patients with rare hereditary problems of galactose intolerance, the lapp lactase deficiency, or glucose-galactose malabsorption
* Patients with score 0(Not assessed) or 1(Normal, not at all ill) in the TS-CGI-S
* Patients participating in other clinical trial
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Years
Maximum Age:
18 Years
Study:
NCT01795105
Study Brief:
Protocol Section:
NCT01795105